Greenwich Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$953K Sell
7,921
-137
-2% -$15.8K 0.04% 156
2025
Q4
$848K Sell
8,058
-279
-3% -$26.2K 0.04% 162
2025
Q3
$700K Buy
8,337
+717
+9% +$59.1K 0.03% 178
2025
Q2
$603K Buy
7,620
+1,205
+19% +$95.8K 0.03% 164
2025
Q1
$576K Sell
6,415
-257
-4% -$24K 0.04% 153
2024
Q4
$664K Buy
6,672
+1,686
+34% +$174K 0.05% 143
2024
Q3
$566K Sell
4,986
-317
-6% -$37.7K 0.04% 160
2024
Q2
$657K Buy
5,303
+45
+0.9% +$5.8K 0.05% 137
2024
Q1
$694K Sell
5,258
-233
-4% -$28.7K 0.06% 139
2023
Q4
$599K Sell
5,491
-499
-8% -$51.8K 0.06% 147
2023
Q3
$617K Sell
5,990
-1,478
-20% -$159K 0.07% 140
2023
Q2
$862K Sell
7,468
-140
-2% -$15.9K 0.09% 115
2023
Q1
$809K Sell
7,608
-162
-2% -$17.5K 0.09% 121
2022
Q4
$862K Buy
7,770
+402
+5% +$41.1K 0.09% 116
2022
Q3
$635K Sell
7,368
-561
-7% -$50.1K 0.07% 139
2022
Q2
$723K Buy
7,929
+871
+12% +$77.2K 0.1% 133
2022
Q1
$579K Buy
7,058
+674
+11% +$53.1K 0.06% 149
2021
Q4
$489K Sell
6,384
-248
-4% -$19.8K 0.04% 167
2021
Q3
$498K Buy
6,632
+2,077
+46% +$158K 0.04% 156
2021
Q2
$354K Sell
4,555
-284
-6% -$21.1K 0.03% 172
2021
Q1
$356K Buy
4,839
+231
+5% +$17K 0.03% 156
2020
Q4
$360K Buy
4,608
+748
+19% +$57.2K 0.03% 143
2020
Q3
$306K Sell
3,860
-909
-19% -$71.2K 0.05% 145
2020
Q2
$352K Buy
4,769
+268
+6% +$20.2K 0.07% 133
2020
Q1
$330K Sell
4,501
-640
-12% -$50.3K 0.07% 126
2019
Q4
$446K Sell
5,141
-139
-3% -$11.4K 0.09% 128
2019
Q3
$424K Sell
5,280
-27
-0.5% -$2.16K 0.08% 129
2019
Q2
$425K Sell
5,307
-106
-2% -$8.12K 0.07% 131
2019
Q1
$430K Buy
5,413
+1,556
+40% +$116K 0.08% 125
2018
Q4
$281K Buy
3,857
+60
+2% +$4.24K 0.06% 149
2018
Q3
$257K Sell
3,797
-1,169
-24% -$74.5K 0.04% 154
2018
Q2
$288K Buy
+4,966
New +$280K 0.05% 147
2018
Q1
Sell
-3,738
Closed -$201K 186
2017
Q4
$201K Buy
3,738
+96
+3% +$5.32K 0.03% 175
2017
Q3
$222K Buy
+3,642
New +$221K 0.04% 159
2017
Q2
Sell
-4,784
Closed -$290K 190
2017
Q1
$290K Buy
+4,784
New +$290K 0.04% 136
2016
Q4
Sell
-3,665
Closed -$218K 208
2016
Q3
$218K Hold
3,665
0.04% 181
2016
Q2
$201K Sell
3,665
-360
-9% -$19.2K 0.05% 180
2016
Q1
$203K Buy
+4,025
New +$197K 0.05% 174
2014
Q2
Sell
-3,962
Closed -$215K 163
2014
Q1
$215K Sell
3,962
-315
-7% -$16.3K 0.01% 148
2013
Q4
$204K Sell
4,277
-141
-3% -$6.45K 0.02% 159
2013
Q3
$201K Buy
+4,418
New +$202K 0.01% 152

Other funds holding MRK

Greenwich Wealth Management's MRK Position: Q1 2026 in Review

Greenwich Wealth Management reduced its Merck (MRK) stake by 1.7% in Q1 2026, selling an estimated $15.8K and leaving 7,921 shares worth $953K. The position accounts for 0.04% of the portfolio, ranked #156.

Greenwich Wealth Management first reported a position in MRK in Q3 2013 and has held it in 41 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Greenwich Wealth Management held 7,921 shares of Merck worth $953K as of Q1 2026.
  • Greenwich Wealth Management sold 137 Merck shares in Q1 2026, an estimated $15.8K.
  • Merck made up 0.04% of Greenwich Wealth Management's portfolio in Q1 2026, its #156 holding.
  • Greenwich Wealth Management first reported a position in Merck in Q3 2013 and has held it in 41 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.